U.S. Markets closed

Boston Scientific to Buy Britain's BTG for $4.2 Billion

TheStreet Staff

Boston Scientific Corp. on Tuesday agreed to buy British healthcare company BTG plc in a $4.2 billion deal. The Marlborough, Mass.-based medical device maker offered $10.77 for each BTG share, representing a premium of 36.